Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00119210 · ClinicalTrials.gov registry record · Phase 4
Pilot Study of Bupropion for Smoking Cessation in Postpartum Non-breastfeeding Women
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00119210: Clinical Trial Phase 4 study, sponsored by Massachusetts General Hospital.
NCT00119210 is a Phase 4 study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00119210, a Phase 4 study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this small preliminary study is to determine whether it is feasible to recruit women smokers who have just delivered a baby and are not breastfeeding into a study that would test whether starting bupropion, a smoking cessation medication, after a baby's birth helps a postpartum woman to stop smoking.
Interventions
- OTHER placebo
- DRUG Bupropion SR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2005-03 |
| Est. Completion | 2006-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00119210
The ClinicalTrials.gov registry entry for NCT00119210 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00119210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00119210 about?
NCT00119210 is a clinical study titled "Pilot Study of Bupropion for Smoking Cessation in Postpartum Non-breastfeeding Women". The purpose of this small preliminary study is to determine whether it is feasible to recruit women smokers who have just delivered a baby and are not breastfeeding into a study that would test whether starting bupropion, a smoking cessation medication, after a baby's birth helps a postpartum woman ...
What is the current status of trial NCT00119210?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2005-03. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00119210?
The interventions under investigation include: placebo (OTHER), Bupropion SR (DRUG).
Who is sponsoring clinical trial NCT00119210?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.